ItemLetter

Platelets to surrogate lung inflammation in COVID-19 patients

Title
Platelets to surrogate lung inflammation in COVID-19 patients
Creator
Kuchi Bhotla H.; Kaul T.; Balasubramanian B.; Easwaran M.; Arumugam V.A.; Pappusamy M.; Muthupandian S.; Meyyazhagan A.
Description
The neoteric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been jeopardizing the world with the symptoms of seasonal flu. The virus contagion predicted to have been originated from Wuhan, China has by far trapped 4,198,418 cases from 212 countries in the world with two international conveyances with 284,102 deaths as of 11 May 2020 (10:18 GMT). Researchers around the globe have indulged in deciphering viral mode in the body for devising a cure. Affirmations from autopsies and preliminary findings on SARS-CoV-2 hypothesized on viral pathogenesis within the host, for instance, source of inflammation in lungs and pneumonia. This hypothesis assigns the platelets as agents of infection after viral entry. Presently, curbing infection to stall the spread of SARS-CoV-2 is the prima facie intervention employed, worldwide. However, public health authorities must monitor the state of affairs scrupulously, as the deeper our understanding of this novel virus and its associated outbreak, the better we can deal with it. Knowing this idea might be far-fetched, yet this postulate would serve as the groundwork for the present situation. 2020 Elsevier Ltd
Source
Medical Hypotheses, Vol-143
Date
2020-01-01
Publisher
Churchill Livingstone
Subject
COVID-19; Lung inflammation; Pathogenesis; Platelets; Thrombocytopenia
Coverage
Kuchi Bhotla H., Department of Medicine, Section of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy; Kaul T., Department of Food Science and Biotechnology, College of Life Science, Sejong University, Seoul, 05006, South Korea; Balasubramanian B., Nutritional Improvement of Crops, International Centre for Genetic Engineering and Biotechnology, New Delhi, 110067, India; Easwaran M., Department of Food Science and Biotechnology, College of Life Science, Sejong University, Seoul, 05006, South Korea; Arumugam V.A., Medical Genetics and Epigenetics Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore, Tamil Nadu, India; Pappusamy M., Department of Life Sciences, CHRIST (Deemed to be University), Bengaluru (Karnataka), 560029, India; Muthupandian S., Department of Medical Microbiology and Immunology, Division of Biomedical Sciences, School of Medicine, College of Health Sciences, Mekelle University, Mekelle, 1871, Ethiopia; Meyyazhagan A., Department of Life Sciences, CHRIST (Deemed to be University), Bengaluru (Karnataka), 560029, India, Euroespes Biomedical Research Centre, International Centre of Neuroscience and Genomic Medicine, Corunna, 15165, Spain
Rights
All Open Access; Green Open Access
Relation
ISSN: 3069877; PubMed ID: 32688185; CODEN: MEHYD
Format
Online
Language
English
Type
Letter

Collection

Letters

Citation

Kuchi Bhotla H.; Kaul T.; Balasubramanian B.; Easwaran M.; Arumugam V.A.; Pappusamy M.; Muthupandian S.; Meyyazhagan A., “Platelets to surrogate lung inflammation in COVID-19 patients,” CHRIST (Deemed To Be University) Institutional Repository, accessed February 23, 2025, https://archives.christuniversity.in/items/show/21204.

Output Formats